Search the Newsreel

Skillful Craftsman Education Technology Ltd (EDTK) Valuation: PE, PB & Fair Value Analysis

This article provides a brief overview of Skillful Craftsman Education Technology Ltd (EDTK), focusing on its valuation metrics. It notes that key financial ratios like P/E, P/B, P/S, and P/CF have not yet been disclosed by the company. The stock is currently trading at …

Fulton Financial Corporation Revenue Breakdown – NASDAQ:FULT

H.B. Fuller (FUL) Could Be 24% Undervalued After Its Debt Refinance

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. H.B. Fuller (FUL) has just reshaped its balance sheet by refinancing $420,000,000 of term loans and expanding its revolving credit facility to $800,000,000, …

Skillful Craftsman Education Technology Ltd (EDTK) Income Statement

This article presents the quarterly and annual income statements for Skillful Craftsman Education Technology Ltd (EDTK), offering detailed financial data from FY2020H1 to FY2025H1. It includes revenue, operating expenses, profit and loss metrics, and earnings per share, alongside FAQs explaining how to interpret the …

Refinancing And Dividend Move Might Change The Case For Investing In H.B. Fuller (FUL)

H.B. Fuller recently refinanced its credit facilities, securing new Term A loans, expanding its revolving credit to US$800 million, and extending maturities to 2031, which improves liquidity and slightly reduces interest expenses. The company also declared a quarterly dividend of US$0.2450 per share. While …

FLGT|Fulgent Genetics Inc|Price:19.670|Chg%:-0.310

Fulgent Genetics Inc (FLGT) trades at $19.670, showing a -1.55% change. The company has healthy fundamentals and significant growth potential, although its valuation is considered fairly valued within the Healthcare Providers & Services industry. One analyst rates FLGT as "Hold" with a target price …

Fulton Financial Corp (FULT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts and an event timeline for Fulton Financial Corp (FULT). It details the company's dividend history, showing the payment, record, and ex-dividend dates, along with the gross cash dividend amounts paid over several years. The information …

Hsbc Holdings PLC Raises Stock Holdings in Full Truck Alliance Co. Ltd. Sponsored ADR $YMM

Hsbc Holdings PLC significantly increased its stake in Full Truck Alliance Co. Ltd. Sponsored ADR (NYSE:YMM) by 62.4% during the first quarter of 2026, acquiring an additional 758,900 shares. This brings their total holdings to 1,975,692 shares, valued at approximately $16.3 million. Despite a …

How Record Operating Earnings, Blue Foundry Deal and Buybacks At Fulton Financial (FULT) Have Changed Its Investment Story

Fulton Financial Corporation recently reported its second-quarter and first-half 2026 results, showing higher net interest income and net income year on year, while earnings per share were essentially flat, and it also completed a US$35.61 million share repurchase of 1,737,650 shares under its December …

Full House Resorts Inc (FLL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of the dividend and stock split history for Full House Resorts Inc (FLL). It notes that no dividend data is available, indicating that the company has not distributed dividends in the past five years. The page also displays current …

Fulgent Genetics, Inc. Revenue Breakdown – FWB:7F0

Fulgent Genetics, Inc. (FWB:7F0) generated €274.73 million in revenue last year, with its Laboratory Services segment contributing the most at €274.35 million. The majority of the revenue, €252.49 million, originated from the United States. This financial overview highlights the company's key revenue streams and …

Fulcrum Therapeutics, Inc. Revenue Breakdown – NASDAQ:FULC

This article from TradingKey provides a revenue breakdown for Fulcrum Therapeutics Inc (FULC). It notes that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page also includes current stock information for FULC.

ETFs Investing in Fulcrum Therapeutics, Inc. Stocks

This article lists several ETFs that hold stocks of Fulcrum Therapeutics, Inc. (FULC), a pharmaceuticals company. The list provides details such as market value, weight of FULC in the ETF, issuer, management style, expense ratio, and recent performance for each fund. These ETFs offer …

Fuller, Smith & Turner P.L.C. Class A Revenue Breakdown – LSE:FSTA

EDTK|Skillful Craftsman Education Technology Ltd|Price:0.900|Chg%:-0.082

This article provides a detailed financial overview of Skillful Craftsman Education Technology Ltd (EDTK), including its real-time stock quotes, market trends, and key financial figures. It highlights the company's focus on online vocational education and technology services within the China market. The report also …

FULT|Fulton Financial Corp|Price:24.570|Chg%:+0.310

Fulton Financial Corp (FULT) is currently trading at $24.570, up 1.28%, with a market cap of $4.70B. The company exhibits healthy fundamentals, high growth potential, and is considered fairly valued within the Banking Services industry. Analysts rate it as a "Buy" with a target …

Full House Resorts Inc (FLL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Full House Resorts Inc (FLL), listing major individual and institutional holders and their respective holdings. It provides quarterly institutional shareholding data showing changes over time, as well as recent shareholder activity by key investors. The report also …

Full House Resorts Inc (FLL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Full House Resorts Inc (FLL), noting its current valuation score of 8.90 within the Hotels & Entertainment Services industry. It highlights the company's P/E ratio of -2.16, indicating its position relative to recent highs and lows. The …

FULT Q2 Deep Dive: Blue Foundry Integration Drives Growth, Margin Stability Remains Focus

FULT Q2 Deep Dive: Blue Foundry Integration Drives Growth, Margin Stability Remains Focus Regional banking company Fulton Financial (NASDAQ:FULT) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 12% year on year to $367.9 million. Its non-GAAP profit of $0.60 …

Why Is H. B. Fuller (FUL) Down 11% Since Last Earnings Report?

Shares of H. B. Fuller (FUL) have decreased by 11% since its last earnings report, underperforming the S&P 500. Despite this, the company reported strong second-quarter fiscal 2026 results with adjusted earnings up 19% year-over-year and revenues exceeding estimates, driven by pricing and currency …

FLL|Full House Resorts Inc|Price:2.400|Chg%:+0.040

Full House Resorts Inc. (FLL) is trading at $2.335 USD, down 2.30%, with a market cap of $84.60M. TradingKey's stock score indicates stable fundamentals, significant growth potential, and a fair valuation, though institutional ownership is high and stock market performance has been weak. Despite …

Fulton Financial (FULT) Stock Faces Flat EPS As Strong Net Interest Margin Supports Bull Narratives

Fulgent Genetics (FLGT) to Release Earnings on Thursday

Fulgent Genetics (FLGT) is scheduled to release its Q2 2026 earnings before market open on Thursday, July 30th, with analysts anticipating a loss of $0.46 per share on revenues of $94.0 million. Wall Street maintains a "Hold" rating for FLGT with a consensus price …

Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP is investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for potential securities law violations. This investigation follows Fulcrum's announcement on June 1, 2026, of the discontinuation of its pociredir program for sickle cell disease due to FDA concerns regarding the drug's …

Fulton Financial (FULT) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, Fulton Financial (FULT) reported revenue of $367.87 million, up 12% over the same period last year. EPS came in at $0.60, compared to $0.55 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

Fulton Financial’s (NASDAQ:FULT) Q2 CY2026 Sales Top Estimates

Fulton Financial's (NASDAQ:FULT) Q2 CY2026 Sales Top Estimates Regional banking company Fulton Financial (NASDAQ:FULT) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 12% year on year to $367.9 million. Its non-GAAP profit of $0.60 per share was 12.6% above analysts' consensus …

FULTON FINANCIAL ($FULT) Releases Q2 2026 Earnings

Fulton Financial Corporation Announces Second Quarter 2026 Results

LANCASTER, Pa., July 22, 2026 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ: FULT) ("Fulton" or the "Corporation") reported net income available to common shareholders of $99.9 million, or $0.52 per diluted share, for the second quarter of 2026, an increase of $7.7 million, or $0.01 …

YMM or SYM: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Technology Services sector might want to consider either Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) or Symbotic Inc. (SYM). But which of these two stocks is more attractive to value investors? We'll need to take a closer …

How (YMM) Movements Inform Risk Allocation Models

This article analyzes Full Truck Alliance Co. Ltd. (NYSE: YMM) using AI models, highlighting strong near and mid-term sentiment but a weak long-term outlook. It identifies compelling upside potential due to a lack of resistance levels above the current price. The report also outlines …

Fulton Financial (FULT) Surpasses Q2 Earnings and Revenue Estimates

Kaplan Fox Announces an Investigation Into Fulcrum Therapeutics

Kaplan Fox & Kilsheimer LLP has initiated an investigation into Fulcrum Therapeutics, Inc. (NASDAQ: FULC) regarding potential securities law violations. This follows a significant drop in Fulcrum's stock price after the company announced the discontinuation of its pociredir program for sickle cell disease due …

FULTON FINANCIAL CORPORATION APPOINTS DAVID S. SCHULZ TO BOARD OF DIRECTORS

LANCASTER, Pa., July 21, 2026 /PRNewswire/ -- Fulton Financial Corporation (NASDAQ: FULT) ("Fulton") today announced the appointment of David S. Schulz as a member of its board of directors (the "Board") for a term commencing September 14, 2026 and expiring at Fulton's 2027 annual …

H.B. Fuller (FUL) Could Be 24% Below Fair Value On Credit Refinancing

H.B. Fuller (FUL) recently refinanced its credit agreement, extending maturities and lowering interest margins, yet its share price has fallen. Despite this, the company is estimated to be 24.4% undervalued, trading at $55.43 against a fair value of $73.29, according to analyst consensus and …

Form 4 Fulcrum Therapeutics Inc For: 21 July By Investing.com

This article reports on a Form 4 filing for Fulcrum Therapeutics Inc. dated July 21st, 2026. Form 4 filings typically disclose transactions by company insiders, however, the content beyond the headline is minimal, indicating this islikely an automated news brief. The article notes a …

5 Value Stocks With Impressive EV-to-EBITDA Ratios to Own Now

This article highlights the EV-to-EBITDA ratio as a superior valuation metric compared to the P/E ratio, especially for identifying undervalued companies or potential acquisition targets. It explains why EV-to-EBITDA provides a clearer view of a company's financial health, accounting for debt and non-cash expenses. …